Matthias is Chief Business Officer at Evotec SE, leading efforts to forge innovative partnerships for groundbreaking medicines, often at the interface between bio-sciences and technology. Evotec is dedicated to fostering global R&D collaborations with diverse partners, from academia to biotech to big pharma. With expertise in biochemistry, molecular biology, and bioinformatics, he draws on 20+ years as an ex-McKinsey Senior Partner and former global co-lead of the pharma/biotech R&D practice, specializing in strategy, operations, and business development in biotech/pharma R&D. His projects span from omics research to AI-driven manufacturing of biologics. As an early-stage investor, he advises at Angelini Ventures, mentors young scientists via the Global Biotech Revolution's network, and publishes regularly.